BioSpace News Archive

Frontera Therapeutics, a global clinical-stage biotechnology company that seeks to develop novel and best-in-class gene therapy medicines to improve the lives of patients across multiple disease areas, today announced that it has dosed the first patient in a Phase 1 clinical trial of its lead gene therapy program, FT-001, for the treatment of Leber Congenital Amaurosis-2, a severe inherited retinal disease related to a mutation in the RPE65 gene.

Seegene Technologies, Inc. announced it will change names and begin doing business as Seegene USA, Inc. , effective Jan. 1, 2023.

NS Pharma announced the opening of a new office in Cambridge, Massachusetts, to establish the NS Pharma Innovation Research Partnering division.

Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH) today announced its fourth quarter earnings conference call will be webcast on Friday, February 3, 2023 at 8:30 a.m. ET.

Blueprint Medicines Corporation (NASDAQ: BPMC) today announced the appointment of John Tsai, M.D., to its board of directors.

SS&C Technologies Holdings, Inc. today announced Rahul Kanwar , President and Chief Operating Officer, will present at the 25th Annual Needham Growth Conference at the Lotte New York Palace.

Jnana Therapeutics today announced that it has received clearance from the U.S. Food and Drug Administration (FDA) of its Investigational New Drug (IND) application for the clinical study of JNT-517 for the treatment of phenylketonuria (PKU).

Vanda Pharmaceuticals Inc. (Vanda) (Nasdaq: VNDA) today announced that the company will participate in the J.P. Morgan Healthcare Conference in San Francisco, California on Thursday, January 12, 2023.

Avantor, Inc. announced that it will release its fourth quarter and full year 2022 financial results before the market opens on Friday, February 3, and will hold a conference call to discuss the results on the same day at 8:00 a.m. Eastern Standard Time.

Bio-Rad Laboratories, Inc. will report its financial results for the fourth quarter and full year 2022 on Thursday, February 16, 2023, following the close of the market.